Certain A-Shares of Jiangsu Apon Medical Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 13-DEC-2021.
December 13, 2021
Share
Certain A-Shares of Jiangsu Apon Medical Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 13-DEC-2021. These A-Shares will be under lockup for 1097 days starting from 12-DEC-2018 to 13-DEC-2021.
Details:
The company's controlling shareholder Wang Ningyu and shareholder Zhang Zhihui committed to not dispose off their holdings in the company for a period of 36 months from the date of listing of the new shares.
The company's shareholders Shanghai Heike Venture Capital Center, Zhang Naizhi, Yin Xuezhi, Nantong Pengzhong Equity Investment Center, Jiangsu Yuyue Technology Development Co., Ltd., Shanghai Guohong Zhizhen Investment Partnership Enterprise, Beijing Tianfeng Qihang Equity Ivnestment Partnership Enterprise, Nantong Jianhua Venture Capital Partnership Enterprise, Nantong Aipu Equity Investment Center, Miu Meng, Li Xiaobing, Gu Dehou and other shareholders committed to not dispose off their holdings in the company for a period of 12 months from the date of listing of the new shares.
The company's directors and senior management members Ye Jianli, Guan Jifeng, Sun Zhuwei, Shen Qin, Wang Xianrong, Li Qing, Miu Fei and Yuan Donglin along with supervisors Gu Aijun, Luan Jianrong and Chen Jianhua committed to not dispose off their holdings in the company for a period of 12 months from the date listing of the new shares.
Jiangsu Apon Medical Technology Co., Ltd. is a China-based company which is mainly engaged in research, development, production and sales of medical device products for pain management and nasal care. The Company's main products include medical devices such as micro-computer injection pumps, disposable drug injection pumps, wireless analgesia management systems, pulse oximeters and sensors for pain management, and nasal care applications such as nasal care sprayers. Among them, medical devices used in the field of pain management are mainly used for infusion and monitoring of drug treatment in postoperative, childbirth, cancer and other clinical treatments to alleviate pain in patients; medical devices used in nasal care are mainly used to relieve nasal dryness, nasal congestion and nose discomfort such as bleeding in patients. The Company operates primarily in domestic and overseas markets.